Abstract
Sp1 is important for the transcription of many genes. Our previous studies have shown that Sp1 is degraded in normal cell, but it is preserved in cancer cells during mitosis and exists a priori in the daughter cells, ready to engage in gene transcription and thereby contributes to the proliferation and survival of cancer cells. The mechanism by which Sp1 is preserved in cancer cells during mitosis remains unknown. In this study, we observed that Sp1 strongly colocalized with cyclin-dependent kinase 1 (CDK1)/cyclin B1 during mitosis. Moreover, we showed that Sp1 is a novel mitotic substrate of CDK1/cyclin B1 and is phosphorylated by it at Thr 739 before the onset of mitosis. Phospho-Sp1 reduced its DNA-binding ability and facilitated the chromatin condensation process during mitosis. Mutation of Thr739 to alanine resulted in Sp1 remaining in the chromosomes, delayed cell-cycle progression, and eventually led to apoptosis. Screening of Sp1-associated proteins during mitosis by using liquid chromatography/mass spectrometry indicated the tethering of Sp1 to myosin/F-actin. Furthermore, phospho-Sp1 and myosin/F-actin appeared to exist as a congregated ring at the periphery of the chromosome. However, at the end of mitosis and the beginning of interphase, Sp1 was dephosphorylated by PP2A and returned to the chromatin. These results indicate that cancer cells use CDK1 and PP2A to regulate the movement of Sp1 in and out of the chromosomes during cell-cycle progression, which may benefit cancer-cell proliferation.
Similar content being viewed by others
References
Abdelrahim M, Smith 3rd R, Burghardt R, Safe S . (2004). Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer Res 64: 6740–6749.
Armstrong SA, Barry DA, Leggett RW, Mueller CR . (1997). Casein kinase II-mediated phosphorylation of the C terminus of Sp1 decreases its DNA binding activity. J Biol Chem 272: 13489–13495.
Benasciutti E, Pages G, Kenzior O, Folk W, Blasi F, Crippa MP . (2004). MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription. Blood 104: 256–262.
Bonello MR, Khachigian LM . (2004). Fibroblast growth factor-2 represses platelet-derived growth factor receptor-alpha (PDGFR-alpha) transcription via ERK1/2-dependent Sp1 phosphorylation and an atypical cis-acting element in the proximal PDGFR-alpha promoter. J Biol Chem 279: 2377–2382.
Boulon S, Dantonel JC, Binet V, Vie A, Blanchard JM, Hipskind RA et al. (2002). Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho-CREB- and CREB binding protein-independent mechanism. Mol Cell Biol 22: 7769–7779.
Chang LK, Chung JY, Hong YR, Ichimura T, Nakao M, Liu ST . (2005). Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1. Nucleic Acids Res 33: 6528–6539.
Chiefari E, Brunetti A, Arturi F, Bidart JM, Russo D, Schlumberger M et al. (2002). Increased expression of AP2 and Sp1 transcription factors in human thyroid tumors: a role in NIS expression regulation? BMC Cancer 2: 35.
Chu S, Ferro TJ . (2005). Sp1: regulation of gene expression by phosphorylation. Gene 348: 1–11.
Chuang JY, Hung JJ . (2011). Overexpression of HDAC1 induces cellular senescence by Sp1/PP2A/pRb pathway. Biochem Biophys Res Commun 407: 587–592.
Chuang JY, Wang YT, Yeh SH, Liu YW, Chang WC, Hung JJ . (2008). Phosphorylation by c-Jun NH2-terminal Kinase 1 Regulates the Stability of Transcription Factor Sp1 during Mitosis. Mol Biol Cell 19: 1139–1151.
Chuang JY, Wu CH, Lai MD, Chang WC, Hung JJ . (2009). Overexpression of Sp1 leads to p53-dependent apoptosis in cancer cells. Int J Cancer 125: 2066–2076.
Guo T, Cornea RL, Huke S, Camors E, Yang Y, Picht E et al. (2010). Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on Ca sparks. Circ Res 106: 1743–1752.
Han I, Kudlow JE . (1997). Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol Cell Biol 17: 2550–2558.
He B, Meng YH, Mivechi NF . (1998). Glycogen synthase kinase 3beta and extracellular signal-regulated kinase inactivate heat shock transcription factor 1 by facilitating the disappearance of transcriptionally active granules after heat shock. Mol Cell Biol 18: 6624–6633.
He S, Davie JR . (2006). Sp1 and Sp3 foci distribution throughout mitosis. J Cell Sci 119: 1063–1070.
Hosoi Y, Watanabe T, Nakagawa K, Matsumoto Y, Enomoto A, Morita A et al. (2004). Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Int J Oncol 25: 461–468.
Hung JJ, Wang YT, Chang WC . (2006). Sp1 deacetylation induced by phorbol ester recruits p300 to activate 12(S)-lipoxygenase gene transcription. Mol Cell Biol 26: 1770–1785.
Kugimiya F, Kawaguchi H, Ohba S, Kawamura N, Hirata M, Chikuda H et al. (2007). GSK-3beta controls osteogenesis through regulating Runx2 activity. PLoS One 2: e837.
Li L, Davie JR . (2010). The role of Sp1 and Sp3 in normal and cancer cell biology. Ann Anat 192: 275–283.
Lou Z, O'Reilly S, Liang H, Maher VM, Sleight SD, McCormick JJ . (2005). Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation. Cancer Res 65: 1007–1017.
Lu KP, Zhou XZ . (2007). The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol 8: 904–916.
Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S . (2007). The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res 67: 11001–11011.
Milanini-Mongiat J, Pouyssegur J, Pages G . (2002). Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription. J Biol Chem 277: 20631–20639.
Safe S, Abdelrahim M . (2005). Sp transcription factor family and its role in cancer. Eur J Cancer 41: 2438–2448.
Saxena UH, Owens L, Graham JR, Cooper GM, Hansen U . (2010). Prolyl isomerase Pin1 regulates transcription factor LSF (TFCP2) by facilitating dephosphorylation at two serine-proline motifs. J Biol Chem 285: 31139–31147.
Strebhardt K . (2010). Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nat Rev Drug Discov 9: 643–660.
Tan NY, Khachigian LM . (2009). Sp1 phosphorylation and its regulation of gene transcription. Mol Cell Biol 29: 2483–2488.
Wang L, Wei D, Huang S, Peng Z, Le X, Wu TT et al. (2003). Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 9: 6371–6380.
Wang YT, Chuang JY, Shen MR, Yang WB, Chang WC, Hung JJ . (2008). Sumoylation of specificity protein 1 augments its degradation by changing the localization and increasing the specificity protein 1 proteolytic process. J Mol Biol 380: 869–885.
Wang YT, Yang WB, Chang WC, Hung JJ . (2011). Interplay of posttranslational modifications in Sp1 mediates Sp1 stability during cell cycle progression. J Mol Biol 414: 1–14.
Xavier IJ, Mercier PA, McLoughlin CM, Ali A, Woodgett JR, Ovsenek N . (2000). Glycogen synthase kinase 3beta negatively regulates both DNA-binding and transcriptional activities of heat shock factor 1. J Biol Chem 275: 29147–29152.
Acknowledgements
This work was supported by the National Cheng Kung University project of the Program for Promoting Academic Excellence and Develo** World Class Research Centers, together with grants NSC 97-2320-B-006-016-MY3 and NSC 97-2311-B-006-002-MY3 obtained from the National Science Council, Taiwan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Chuang, JY., Wang, SA., Yang, WB. et al. Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells. Oncogene 31, 4946–4959 (2012). https://doi.org/10.1038/onc.2011.649
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2011.649
- Springer Nature Limited
Keywords
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.